Drug Pricing, Patient Welfare, and Cost-Effectiveness Analysis
Value in Health · 2024
DOI: 10.1016/j.jval.2024.01.006 ↗Kurz gefasst
Editorial in der Zeitschrift Value in Health, 2024. Verfasst von Pieter van Baal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Cost-Effectiveness Analysis, Drug Costs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 7 Literaturangaben. Gefördert von: Horizon Europe.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
- Nova School of Business and Economics, Campus de Carcavelos, Lisboa, Portugal. Electronic address: vanbaal@eshpm.eur.nl.
Förderung
- Horizon Europe
Zitieren
APA
van Baal, P., & Barros, P. P. (2024). Drug Pricing, Patient Welfare, and Cost-Effectiveness Analysis. Value in Health. https://doi.org/10.1016/j.jval.2024.01.006
Vancouver
van Baal P, Barros PP. Drug Pricing, Patient Welfare, and Cost-Effectiveness Analysis. Value in Health. 2024. doi:10.1016/j.jval.2024.01.006
BibTeX
@article{vanBaal2024,
author = {van Baal, Pieter and Barros, Pedro Pita},
title = {Drug Pricing, Patient Welfare, and Cost-Effectiveness Analysis},
journal = {Value in Health},
year = {2024},
doi = {10.1016/j.jval.2024.01.006}
}
EUVIMED